You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Immune checkpoint inhibitor plus tyrosine kinase inhibitor with or without transarterial chemoembolization for unresectable hepatocellular carcinoma
- 2. Histogram analysis of multiple mathematical diffusion-weighted imaging models for preoperative prediction of Ki-67 expression in hepatocellular carcinoma
- 3. Nwd1 gene deletion triggers MASH-like pathology in mice
- 4. Unlocking the hidden proteome: The role of coding circular RNA in cancer
- 5. How environmental exposures affect genes and increase cancer risk
- 6. Secret boss of the liver: Star-shaped cells that promote fibrosis also regulate liver health
- 7. Prostate cancer is not a death knell, study shows
- 8. Pfizer and Arvinas's HER2-breast cancer drug extends PFS in certain patients
- 9. Breast Cancer Diagnostics Market Set for 6.9% CAGR Growth, projected to Hit USD 12.45 Billion by 2035
- 10. Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study
Last updated at 21:12 GMT
Hot News Makers
Health/Pharma Companies
-
34230.29
-
33359.50
-
18799.95
-
12252.06
-
8930.10
-
8639.30
-
8382.30
-
8363.58
-
6983.30
-
5148.36
Drugs, Treatments, Trials
-
19042.96
-
8244.02
-
6275.88
-
6197.92
-
5090.03
-
4777.49
-
4541.35
-
4192.49
-
3602.30
-
2828.53
Last updated at 20:10 GMT
